The U.S. Food and Drug Administration announced earlier this month that it will be phasing out animal testing for some new ...

DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines.

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

Google DeepMind CEO, Demis Hassabis, a Nobel laureate, envisions AI revolutionizing healthcare, potentially curing all ...

Hassabis pointed out the potential of AI to transform medicine by significantly lessening the time and expense of drug ...

Ex-Google CEO Eric Schmidt warns AI could surpass human control by 2026. Discover the risks and opportunities of artificial ...

Nobel laureate and DeepMind CEO Demis Hassabis envisions a future where AI revolutionizes healthcare by drastically accelerating drug development—from years to weeks—and potentially curing all ...

Eric Schmidt’s AI predictions reveal a future of innovation, risks, and ethical dilemmas. Are we ready for the rise of ...

AstraZeneca, Tempus and Pathos will develop an AI-driven foundational model to develop therapeutics in oncology.

Rakovina Therapeutics remains committed to leveraging world-class science and technology to develop new treatments for ...